Cited by

• The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

  Diaz LA Jr, Williams RT, Wu J, Kinde I, Hecht JR, Berlin J, Allen B, Bozic I, Reiter JG, Nowak MA, Kinzler KW, Oliner KS, Vogelstein B. Diaz LA Jr, et al. Nature. 2012 Jun 28;486(7404):537-40. doi: 10.1038/nature11219. Nature. 2012. PMID: 22722843 Free PMC article.
• Noninvasive detection of HER2 amplification with plasma DNA digital PCR.

  Gevensleben H, Garcia-Murillas I, Graeser MK, Schiavon G, Osin P, Parton M, Smith IE, Ashworth A, Turner NC. Gevensleben H, et al. Clin Cancer Res. 2013 Jun 15;19(12):3276-84. doi: 10.1158/1078-0432.CCR-12-3768. Epub 2013 May 1. Clin Cancer Res. 2013. PMID: 23637122 Free PMC article.
• Picoliter Well Array Chip-Based Digital Recombinase Polymerase Amplification for Absolute Quantification of Nucleic Acids.

  Li Z, Liu Y, Wei Q, Liu Y, Liu W, Zhang X, Yu Y. Li Z, et al. PLoS One. 2016 Apr 13;11(4):e0153359. doi: 10.1371/journal.pone.0153359. eCollection 2016. PLoS One. 2016. PMID: 27074005 Free PMC article.
• HPTLC-aptastaining - Innovative protein detection system for high-performance thin-layer chromatography.

  Morschheuser L, Wessels H, Pille C, Fischer J, Hünniger T, Fischer M, Paschke-Kratzin A, Rohn S. Morschheuser L, et al. Sci Rep. 2016 May 25;6:26665. doi: 10.1038/srep26665. Sci Rep. 2016. PMID: 27220270 Free PMC article.
• Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.

  Franczak C, Witz A, Geoffroy K, Demange J, Rouyer M, Husson M, Massard V, Gavoille C, Lambert A, Gilson P, Gambier N, Scala-Bertola J, Merlin JL, Harlé A. Franczak C, et al. PLoS One. 2020 Jan 15;15(1):e0227294. doi: 10.1371/journal.pone.0227294. eCollection 2020. PLoS One. 2020. PMID: 31940389 Free PMC article.